NCT07025369 2026-03-13
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06389786 2025-10-24
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
Mayo Clinic
Phase NA Recruiting
NCT03209076 2019-10-16
RAR
Instituto Nacional de Cancer, Brazil
Phase NA Unknown
NCT03447106 2018-03-02
Cooladvrsigcr
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown